A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury

Clinical Infectious Diseases

Volumn 39, Issue 5, 2004, Pages 658-664

  Dow, Gordon ^a,b   Rao, Pramila ^c,d   Harding, Godfrey ^a,b,e   Brunka, Joanna ^a   Kennedy, Jim ^e   Alfa, Michelle ^a,e   Nicolle, Lindsay E ^a,b,f  

^a Department of Medical Microbiology ^*  (Canada)

^b Section of Infectious Diseases   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d HEALTH SCIENCES CENTRE   (Canada)

^e ST BONIFACE GENERAL HOSPITAL   (Canada)

^f Health Sciences Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STRUVITE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HUMAN; HYDRONEPHROSIS; INDWELLING CATHETER; KLEBSIELLA; LONG TERM CARE; MALE; PRIORITY JOURNAL; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SPINAL CORD INJURY; TREATMENT FAILURE; URINARY TRACT INFECTION;

ACUTE DISEASE; ADULT; CIPROFLOXACIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOCCUS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KLEBSIELLA; MALE; PROSPECTIVE STUDIES; SPINAL CORD INJURIES; URINARY TRACT INFECTIONS;

EID: 4444278927     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/423000     Document Type: Article

References (22)

1. Stover SL. Management of bacteriuria and infection in neurogenic bladder. Phys Med Rehabil Clin North Am 1993; 4:343-62.
2. DeVivo M, Kartus P, Stover S, Rutt R, Fine P. Cause of death for patients with spinal cord injuries. Arch Intern Med 1989; 149:1761-6.
3. Ditunno JF Jr, Formal CS. Chronic spinal cord injury. N Engl J Med 1994; 330:550-6.
4. Cardenas D, Hooton T. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil 1995; 76:272-80.
5. Selzman A, Hampel N. Urologic complications of spinal cord injury. Urol Clin North Am 1993; 20:453-64.
6. Waites K, Canupp K, DeVivo M. Epidemiology and risk factors for urinary tract infection following spinal cord injury. Arch Phys Med Rehabil 1993; 74:691-5.
7. Stamm W, Hooton T. Management of urinary tract infections in adults. N Engl J Med 1993; 329:1328-34.
8. Lewis R, Carrion H, Lockhart J, Politano V. Significance of asymptomatic bacteriuria in neurogenic bladder disease. Urology 1984; 23: 343-7.
9. Gribble M, Puterman M. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med 1993; 95:141-52.
10. Sandock D, Gothe B, Bodner D. Trimethoprim-sulfamethoxazole prophylaxis against urinary tract infection in the chronic spinal cord injury patient. Paraplegia 1995; 33:156-60.
11. Kuhlemeier K, Stover S, Lloyd L. Prophylactic antibacterial therapy for preventing urinary tract infections in spinal cord injury patients. J Urol 1985; 134:514-7.
12. Nicolle LE, Harding GKM, Thomson M, Kennedy J, Urias B, Ronald AR. Efficacy of five years of continuous low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection. J Infect Dis 1988; 157:1239-42.
13. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1998; 28:2059-63.
14. Mohler J, Cowen D, Flanigan R. Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. J Urol 1987; 138:336-40.
15. Hooton T, O'Shaughnessy E, Clowers D, Mack L, Cardenas D, Stamm W. Localization of urinary tract infection in patients with spinal cord injury. J Infect Dis 1984; 150:85-91.
16. Kuhlemeier KV, Lloyd LK, Stover SL. Failure of antibody-coated bacteria and bladder washout tests to localize infection in spinal cord injury patients. J Urol 1983; 130:729-32.
17. Reid G, Potter P, Delaney G, Hsieh J, Nicosia S, Hayes K. Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury. Int J Antimicrob Agents 2000; 13:305-7.
18. Brooun A, Liu S, Lewis K. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2000; 44:640-6.
19. Sanders C, Sanders W, Goering R. Overview of preclinical studies with ciprofloxacin. Am J Med 1987; 82:2-11.
20. Stamm W, Hooton T, Johnson J, et al. Urinary tract infections: from pathogenesis to treatment. J Infect Dis 1989; 159:400-6.
21. Stamm W. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med 1991; 91:65S-71S.
22. The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research Consensus Statement. January 27-29, 1992. J Am Paraplegia Soc 1992; 15:194-204.